title: FDG PET/CT in ovarian cancer: what about treatment response and prognosis?
authors.affiliation: Department of Nuclear Medicine, PET/CT Centre, Santa Maria della Misericordia Hospital, Rovigo, Italy. gagra57@libero.it
authors.forename: Gaia
authors.initials: G
authors.lastname: Grassetto
authors.forename: David
authors.initials: D
authors.lastname: Groheux
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Marzola
authors.forename: Elif
authors.initials: E
authors.lastname: Hindié
authors.forename: Adil
authors.initials: A
authors.lastname: Al-Nahhas
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D010051:Ovarian Neoplasms / Q000145:classification* / Q000175:diagnosis*; D049268:Positron-Emission Tomography / Q000379:methods*; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019788:Fluorodeoxyglucose F18